Western Europe
The Western Europe Pharma & Healthcare Insight service provides analysis, forecasts and company profiles on a country-by-country basis, covering the key trends impacting pharma and healthcare markets across Western Europe. The service includes access to the very latest analysis plus a searchable archive of articles and data.
› To gain FREE trial access for a limited period, click trial.
Germany / Industry
German Health Minister Philipp Roesler is considering the implementation of compulsory discounts and price freezes on pharmaceuticals in order to limit the rising cost of healthcare. Germany's per-capita pharmaceutical expenditure is high compared with other European markets and pharmaceutical expenditure in the world's third-largest market reached EUR38.15bn (US$53.73bn) in 2009....
2010-03-09Germany / Industry
Multinational drugmaker Bayer is looking to expand its presence in emerging markets and has highlighted the BRIC (Brazil, Russia, India and China), Mexico, South Korea and Turkey...
2010-03-05Finland / Industry
Finland's national pharmaceutical industry association, Pharma Industry Finland (PIF), has stated that the reference pricing system, implemented in April 2009, has generated EUR85mn...
2010-03-05Industry Developments
Germany
German Health Minister Philipp Roesler is considering the implementation of compulsory discounts and price freezes on pharmaceuticals in order to limit the rising cost of healthcare....
2010-03-09Germany
Multinational drugmaker Bayer is looking to expand its presence in emerging markets and has highlighted the BRIC (Brazil, Russia, India and China), Mexico, South Korea and Turkey...
2010-03-05Finland
Finland's national pharmaceutical industry association, Pharma Industry Finland (PIF), has stated that the reference pricing system, implemented in April 2009, has generated EUR85mn...
2010-03-05Anglo-Swedish multinational drugmaker AstraZeneca posted revenues of US$32.8bn for 2009, a 3% increase on US$31.6bn the previous year. The drugmaker also achieved a staggering 23%...
2010-03-04
